Skip to content
HowShorted

Altimmune, Inc. short interest in 2026

In 2026, Altimmune, Inc.'s disclosed short interest ran from 25.33% of shares outstanding on 15 Jan 2026 to 26.60% on 15 Sep 2026, a change of +1.27 percentage points. The year's high was 27.25% on 30 Apr 2026 and its low 19.35% on 15 May 2026, averaging 23.52% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.38 days on 15 Sep 2026. Full history: Altimmune, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Altimmune, Inc. in 2026

2026 in figures

Start of year
25.33% (15 Jan 2026)
End of year
26.60% (15 Sep 2026)
Change
+1.27 pp
High
27.25% (30 Apr 2026)
Low
19.35% (15 May 2026)
Average
23.52%
Highest days to cover
15.38 (15 Sep 2026)
SEC filings marked
6

Every report in 2026

Altimmune, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202625.33%4.24
30 Jan 202623.18%3.50
13 Feb 202624.11%7.24
27 Feb 202619.60%9.97
13 Mar 202620.36%6.96results (8-K), 10-K filed
31 Mar 202622.49%7.65
15 Apr 202622.09%13.71
30 Apr 202627.25%4.93
15 May 202619.35%11.0210-Q filed, results (8-K)
29 May 202620.12%14.46
15 Jun 202621.56%14.57
30 Jun 202624.49%8.07
15 Jul 202624.81%12.52
31 Jul 202626.71%11.45
14 Aug 202626.20%11.0410-Q filed, results (8-K)
31 Aug 202625.56%11.84
15 Sep 202626.60%15.38

See also: Altimmune, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.